{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1390282679450140800.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.11347/pda.13.35"}},{"identifier":{"@type":"URI","@value":"https://pmda.repo.nii.ac.jp/records/2000436"}},{"identifier":{"@type":"URI","@value":"https://pmda.repo.nii.ac.jp/records/2000435"}},{"identifier":{"@type":"NAID","@value":"130004851459"}},{"identifier":{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2012148601"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"en","@value":"ICH Q11 Development and Manufacture of Drug Substances -Commentary Part 1: How main arguments were developed-"},{"@language":"ja","@value":"ＩＣＨ　Ｑ１１　原薬の開発と製造～議論の経緯と解説～（１）"}],"dc:language":"ja","creator":[{"@id":"https://cir.nii.ac.jp/crid/1410853646935312000","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000283357792"}],"foaf:name":[{"@language":"en","@value":"TAKAGI Kazunori"},{"@language":"ja","@value":"高木 和則"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Pharmaceuticals & Medical Devices Agency"},{"@language":"ja","@value":"独立行政法人医薬品医療機器総合機構"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13444891"},{"@type":"EISSN","@value":"18811728"},{"@type":"ISSN","@value":"13444891"}],"prism:publicationName":[{"@language":"en","@value":"PDA Journal of GMP and Validation in Japan"},{"@language":"ja","@value":"日本PDA学術誌 GMPとバリデーション"},{"@language":"en","@value":"PDA J. GMP Valid. Jpn"},{"@language":"ja","@value":"日本ＰＤＡ学術誌　ＧＭＰとバリデーション"}],"dc:publisher":[{"@language":"en","@value":"Parenteral Drug Association Japan Chapter"},{"@language":"ja","@value":"一般社団法人日本PDA製薬学会"}],"prism:publicationDate":"2011","prism:volume":"13","prism:number":"1","prism:startingPage":"35","prism:endingPage":"39"},"url":[{"@id":"https://pmda.repo.nii.ac.jp/records/2000436"},{"@id":"https://pmda.repo.nii.ac.jp/records/2000435"},{"@id":"https://search.jamas.or.jp/link/ui/2012148601"}],"availableAt":"2011","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=ICH%20Q11","dc:title":"ICH Q11"},{"@id":"https://cir.nii.ac.jp/all?q=QbD","dc:title":"QbD"},{"@id":"https://cir.nii.ac.jp/all?q=Drug%20Substance","dc:title":"Drug Substance"}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:0038313332"},{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:07563:0007340311"},{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:07563:0007340310"},{"@type":"CIA","@value":"130004851459"}]}